C Ardanuy

Summary

Publications

  1. ncbi Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain
    Virginie Mick
    Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Feixa Llarga s n 08907 Hospitalet de Llobregat, Barcelona, Spain
    BMC Microbiol 10:68. 2010
  2. ncbi Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain
    Dora Rolo
    Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona, IDIBELL, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    BMC Microbiol 9:80. 2009
  3. ncbi Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period
    J Linares
    Hospital Universitari de Bellvitge and Universitat de Barcelona IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    Clin Microbiol Infect 16:402-10. 2010
  4. ncbi Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain
    Laura Calatayud
    Servicio de Microbiologia, Hospital Universitario de Bellvitge, Feixa Llarga s n 08907, L Hospitalet de Llobregat, Barcelona, Spain
    Antimicrob Agents Chemother 51:3240-6. 2007
  5. ncbi An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase
    C Pena
    Infectious Disease Service, Hospital de Bellvitge, Universidad de Barcelona, Barcelona, Spain
    J Hosp Infect 47:53-9. 2001
  6. ncbi Pneumococci can persistently colonize adult patients with chronic respiratory disease
    A Domenech
    Microbiology Department, Hospital Universitari de Bellvitge Universitat de Barcelona, IDIBELL, Barcelona, Spain
    J Clin Microbiol 50:4047-53. 2012
  7. ncbi Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone
    C Ardanuy
    Servicio de Microbiologia, Hospital de Bellvitge, Barcelona, Spain
    Antimicrob Agents Chemother 50:3162-5. 2006
  8. ncbi Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease
    I Grau
    Infectious Disease Service, IDIBELL, CibeRes, Hospital Bellvitge, University of Barcelona, Barcelona, Spain
    HIV Med 10:488-95. 2009
  9. ncbi Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes
    C Garcia-Vidal
    Infectious Disease Department, Hospital Universitari de Bellvitge, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Thorax 65:77-81. 2010
  10. ncbi Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia
    S Padrones
    Respiratory Medicine, Institut d Investigació Biomèdica de Bellvitge IDIBELL, University of Barcelona, L Hospitalet de Llobregat, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 29:1243-51. 2010

Collaborators

Detail Information

Publications12

  1. ncbi Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, Spain
    Virginie Mick
    Microbiology Department, Hospital Universitari de Bellvitge, University of Barcelona, IDIBELL, Feixa Llarga s n 08907 Hospitalet de Llobregat, Barcelona, Spain
    BMC Microbiol 10:68. 2010
    ....
  2. ncbi Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain
    Dora Rolo
    Microbiology Department, Hospital Universitari de Bellvitge, Universitat de Barcelona, IDIBELL, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    BMC Microbiol 9:80. 2009
    ....
  3. ncbi Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period
    J Linares
    Hospital Universitari de Bellvitge and Universitat de Barcelona IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain
    Clin Microbiol Infect 16:402-10. 2010
    ..The dynamic character of serotypes and antibiotic resistance in S. pneumoniae should be controlled by a policy of prudent antibiotic use and by implementation of the new generation of conjugate vaccines...
  4. ncbi Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain
    Laura Calatayud
    Servicio de Microbiologia, Hospital Universitario de Bellvitge, Feixa Llarga s n 08907, L Hospitalet de Llobregat, Barcelona, Spain
    Antimicrob Agents Chemother 51:3240-6. 2007
    ....
  5. ncbi An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase
    C Pena
    Infectious Disease Service, Hospital de Bellvitge, Universidad de Barcelona, Barcelona, Spain
    J Hosp Infect 47:53-9. 2001
    ..Our study shows that ESBL-KP bacteraemia occurring in an epidemic ICU setting is mainly catheter-related. We did not find ESBL strains to be associated with a significantly poor outcome...
  6. ncbi Pneumococci can persistently colonize adult patients with chronic respiratory disease
    A Domenech
    Microbiology Department, Hospital Universitari de Bellvitge Universitat de Barcelona, IDIBELL, Barcelona, Spain
    J Clin Microbiol 50:4047-53. 2012
    ..QRDR changes involved in fluoroquinolone resistance were frequently observed in persistent strains after fluoroquinolone treatment; however, the PBP sequences and MLST genotypes of these strains were stable over time...
  7. ncbi Increase of the M phenotype among erythromycin-resistant Streptococcus pneumoniae isolates from Spain related to the serotype 14 variant of the Spain9V-3 clone
    C Ardanuy
    Servicio de Microbiologia, Hospital de Bellvitge, Barcelona, Spain
    Antimicrob Agents Chemother 50:3162-5. 2006
    ..7%), the rate of the M phenotype increased from 3.3% to 8.9% (P < 0.01). Clonal dissemination of mef(E)-carrying strains of serotype 14 variant of the Spain(9V)-3 clone was the major contributor to this increase...
  8. ncbi Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease
    I Grau
    Infectious Disease Service, IDIBELL, CibeRes, Hospital Bellvitge, University of Barcelona, Barcelona, Spain
    HIV Med 10:488-95. 2009
    ..The aim of the study was to describe trends and risk factors for mortality and changes in antibiotic resistance, serotypes and clones among HIV-infected patients with invasive pneumococcal disease (IPD)...
  9. ncbi Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes
    C Garcia-Vidal
    Infectious Disease Department, Hospital Universitari de Bellvitge, Feixa Llarga s n, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Thorax 65:77-81. 2010
    ..The aim of this study was to identify risk factors for septic shock and to ascertain patient outcomes. Serotypes, genotypes and antibiotic resistance of isolated strains were also analysed...
  10. ncbi Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia
    S Padrones
    Respiratory Medicine, Institut d Investigació Biomèdica de Bellvitge IDIBELL, University of Barcelona, L Hospitalet de Llobregat, Barcelona, Spain
    Eur J Clin Microbiol Infect Dis 29:1243-51. 2010
    ..016). Our data suggest that systemic expression of IL-6 production in patients with PP correlates with prognosis. Initial combination antibiotic therapy produces a faster decrease in this cytokine in the first 48 h...
  11. ncbi Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain
    M Santin
    Department of Infectious Diseases, Hospital Universitari de Bellvitge, Barcelona, Spain
    Epidemiol Infect 132:425-32. 2004
    ..kansasii disease in our area. M. kansasii disease in our geographical area was almost exclusively caused by subtype I regardless of HIV status...
  12. ncbi Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii
    A Montero
    Laboratory of Experimental Infection, Infectious Disease Service Microbiology Department, Hospital de Bellvitge, University of Barcelona, 08907 L Hospitalet de Llobregat, Barcelona, Spain
    Antimicrob Agents Chemother 46:1946-52. 2002
    ..baumannii strains. Other alternatives, including combinations with rifampin, may offer better therapeutic profiles and thus should be studied...